HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01.
As of March 2, 2020, Harvard Bioscience, Inc. (the “Company”) and Chane Graziano, the former Chief Executive Officer of the Company, entered into a Consulting Agreement (the “Consulting Agreement”). to the Consulting Agreement, Mr. Graziano has agreed to consult with the Company, as requested by the Company. The Company will reimburse Mr. Graziano for reasonable out-of-pocket travel expenses related thereto. The Consulting Agreement also provides, among other things, that Mr. Graziano or his representatives will vote all shares of the Company’s common stock beneficially owned by him in accordance with the recommendations of the Board of Directors of the Company. Based solely upon ownership information provided to the Company by Mr. Graziano, he is the beneficial owner of approximately 2.5 million shares of our common stock, which excludes shares owned by his family members that are not controlled by Mr. Graziano.
A copy of the Consulting Agreement is attached as Exhibit 10.1 hereto and is incorporated by reference. The foregoing description of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the Consulting Agreement.
(d) Exhibits.
| 10.1 | Consulting Agreement, dated as of March 2, 2020, by and between Harvard Bioscience, Inc. and Chane Graziano. |
HARVARD BIOSCIENCE INC Exhibit
EX-10.1 2 exh_101.htm EXHIBIT 10.1 Exhibit 10.1 Harvard Bioscience March 2,…
To view the full exhibit click here
About HARVARD BIOSCIENCE, INC. (NASDAQ:HBIO)
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company’s products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company’s product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company’s products consist of instruments, consumables and systems that are made up of various individual products.